Alyssa Tapley named in list of leading global health leaders

16 Feb 2026, noon

A red and black framed picture of a young woman smiling at the camera holding up two fingers in the 'peace' sign

Alyssa Tapley, 17 from Leicester, has been named in TIME’S 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.

TIME Magazine describes the list as “spotlight(ing) the 100 most influential leaders in health this year. As the global order has shifted, these titans, innovators, leaders, pioneers, and catalysts have pushed new ideas—from gene therapies to regulatory agencies—ahead to build healthier populations around the world.”

When Alyssa was 13, she agreed to be the first person in the world to receive a treatment made through base-editing - a new way to create a potentially powerful treatment for her cancer, but it had never been tried before. Her bravery was the first step in a clinical trial that has helped adults and children, and has now been extended to a further 10 patients with Relapsed T-cell Leukaemia.

Alyssa said: "It was four years ago when I first met Professor Qasim and his amazing team , I am so thankful to be here and honoured to be named one of the TIME Top 100 Health Influencers. This moment is not just about me, but belongs to every person who has supported and encouraged me on my journey"

Chief Executive from GOSH, Matthew Shaw, said: “This recognition is a powerful tribute to Alyssa’s extraordinary courage and to Professor Qasim’s unwavering commitment to pushing the boundaries of science in the service of children. Alyssa’s willingness to step into the unknown, and maturity at such a young age, has already helped change what is possible for others.

“We are immensely proud of the huge variety of teams that work together for Alyssa, and young people like her, to make a real difference to lives around the world.”

The full list and related tributes appear in the 2/23 issue, available on newsstands on Friday, February 13, 2026, and now at http://time.com/time100health.

Engineered tissue offers hope for children born with ‘missing’ food pipe

Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown oesophagus - the food pipe - shown to safely replace a full section of the organ and restore normal function, including swallowing, in

GOSH celebrates Rare Disease Day 2026 with local community

GOSH specialises in rare disease research and to celebrate, we recently invited two local North London Year 4 classes to join us for the day to learn about how we care for patients with rare diseases.

Professor Francesco Muntoni wins prestigious research prize

Professor Francesco Muntoni, GOSH Paediatric Neurology Consultant, has been awarded the 2026 Novo Nordisk Prize in recognition of his pioneering work transforming the outlook for children with Duchenne muscular dystrophy (DMD).

GOSH secures £1.4m in NIHR capital equipment funding to boost research capability

This investment will significantly strengthen our research infrastructure and enhance our ability to deliver world‑leading paediatric research across the whole hospital.